TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17400833

Group type: EXPERIMENTAL
Intervention: Position of power
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Power motivation under unstable dominance hierarchy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Irrevocable power with no bearing on choices
Number of subjects: 0
Study: 15767216

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 8
Study: 12463106

Group type: EXPERIMENTAL
Intervention: Vitamin E (200 IU/day)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 9421099

Group type: EXPERIMENTAL
Intervention: 200 mg itraconazole orally once a day for 5 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo orally once a day for 5 days
Number of subjects: 10
Study: 7984564

Group type: EXPERIMENTAL
Intervention: Immunologic studies in 15 histiocytosis X patients
Number of subjects: 24
Study: 3433371

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus weekly low-dose cisplatin
Number of subjects: 54

Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 54
Study: 28391730

Group type: EXPERIMENTAL
Intervention: Counselling group (didactic HPV presentation + factsheet)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Leaflet group (written HPV factsheet)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Both groups (leaflet and counselling)
Number of subjects: 121
Study: 27840834

Group type: EXPERIMENTAL
Intervention: Lay Health Trainer (LHT) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 24854966

Group type: EXPERIMENTAL
Intervention: Alcohol Use Disorder (AUD)
Number of subjects: 763

Group type: EXPERIMENTAL
Intervention: Situational factors (frequency of having sex with a partner in a shebeen, tavern, or bottle store)
Number of subjects: 763
Study: 22986144

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel (125 mg/m² IV over 30 minutes on days 1, 8, and 15 of each 28-day cycle)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel
Number of subjects: 35
Study: 20151129

Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone (8 mg)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study: 18516888

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with 1% hyperbaric lidocaine 1 ml (10 mg) (group L)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Propofol general anesthesia (1.0 mg x kg(‐1) injected at 180 mg x kg(‐1) x hr(‐1) followed by continuous infusion at 8 mg x kg(‐1) x hr(‐1) (group P)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with 1% hyperbaric lidocaine (group L)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Propofol general anesthesia (group P)
Number of subjects: 80
Study: 16103847

Group type: EXPERIMENTAL
Intervention: Educational video plus usual care
Number of subjects: 405

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 405
Study: 11790169

Group type: EXPERIMENTAL
Intervention: Itraconazole (200 mg, twice daily for 6 months)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Placebo (twice daily for 6 months)
Number of subjects: 239
Study: 10086433

Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy (stimulus control, sleep restriction, sleep hygiene, and cognitive therapy)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy (temazepam)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Combined behavioral and pharmacological therapy
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 7669238

Group type: EXPERIMENTAL
Intervention: Chilled cabbage leaves
Number of subjects: 28

Group type: COMPARATOR
Intervention: Room temperature cabbage leaves
Number of subjects: 28
Study: 1922223

Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg slow-release preparation every 8 hours)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 21
Study: 6214058

Group type: EXPERIMENTAL
Intervention: Fresh donor specific transfusions (DST)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Stored donor specific transfusions (DST)
Number of subjects: 18
Study: 30300047

Group type: COMPARATOR
Intervention: 3 mg·kg‐1 caffeine
Number of subjects: 15

Group type: COMPARATOR
Intervention: 1 or 2 mg·kg‐1 caffeine
Number of subjects: 15
Study: 29317362

Group type: EXPERIMENTAL
Intervention: Dorsal Root Ganglion Block before Pulsed Radiofrequency (DRG-PRF)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dorsal Root Ganglion Pulsed Radiofrequency (DRG-PRF) without DRG block
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness comparison
Number of subjects: 60
Study: 26560094

Group type: EXPERIMENTAL
Intervention: Nurse-based program of home-delivered care (up to eight visits over 1 year)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 236
Study: 25131925

Group type: EXPERIMENTAL
Intervention: Heart Failure Management Program (HFMP)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard treatment by general practitioner (GP)
Number of subjects: 160
Study: 20708393

Group type: EXPERIMENTAL
Intervention: Intensive therapeutic lifestyle changes (TLSC) program
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional medical care (control group, CG)
Number of subjects: 150
Study: 19011145

Group type: EXPERIMENTAL
Intervention: Enterex Diabetic
Number of subjects: 14

Group type: COMPARATOR
Intervention: Glucerna SR
Number of subjects: 14
Study: 17710288

Group type: EXPERIMENTAL
Intervention: Fluoride‐releasing elastomeric ligature ties (Fluor‐I‐Ties, Ortho Arch Co. Inc., USA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional elastomeric ligature ties (D. Morelli, Brazil)
Number of subjects: 40
Study: 15085512

Group type: EXPERIMENTAL
Intervention: Ultrasonography (US) at the medial orbital rim
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Ultrasonography (US) at the lateral orbital rim
Number of subjects: 62

Group type: COMPARATOR
Intervention: Computed Tomography (CCT) as reference method
Number of subjects: 62
Study: 12324292

Group type: COMPARATOR
Intervention: Threonine intake of 7 mg x kg(‐1) x d(‐1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Threonine intake of 11 mg x kg(‐1) x d(‐1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Threonine intake of 15 mg x kg(‐1) x d(‐1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Threonine intake of 19 mg x kg(‐1) x d(‐1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Threonine intake of 22 mg x kg(‐1) x d(‐1)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Threonine intake of 27 mg x kg(‐1) x d(‐1)
Number of subjects: 16
Study: 9647135

Group type: EXPERIMENTAL
Intervention: Aprotinin (high dose)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Aprotinin (low dose)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Pump prime only
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 7856808

Group type: EXPERIMENTAL
Intervention: Functional knee brace
Number of subjects: 6

Group type: COMPARATOR
Intervention: Unbraced leg
Number of subjects: 6
Study: 2813660

Group type: EXPERIMENTAL
Intervention: Codeine (30 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Oxazepam (30 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 883811

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ) 960 mg TMP and 4800 mg SMZ
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 29951886

Group type: EXPERIMENTAL
Intervention: Metoprolol (47.5 mg once daily)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Amlodipine (5 mg once daily)
Number of subjects: 100
Study: 27802097

Group type: EXPERIMENTAL
Intervention: Oral oxandrolone (Ox) 0.06 mg/kg/d for 2 years
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo for 2 years
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Oral oxandrolone (Ox)
Number of subjects: 93
Study: 26246443

Group type: COMPARATOR
Intervention: Pharmacological modulation using selective antagonists for µ‐opioid, dopamine D3 receptor (DRD3), and neurokinin 1 (NK1) receptors (naltrexone, GSK598809, vofopitant/aprepitant) in a placebo-controlled, randomised, crossover design.
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study: 24012493

Group type: EXPERIMENTAL
Intervention: Bilateral TAP block with 0.5% ropivacaine
Number of subjects: 51

Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 51
Study: 21517204

Group type: EXPERIMENTAL
Intervention: Previous practice with the interruption task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Previous practice with specific primary and interruption task-pair
Number of subjects: 0

Group type: COMPARATOR
Intervention: Experience with other primary and interruption task-pairs or practice on the primary task alone
Number of subjects: 0
Study: 18358117

Group type: EXPERIMENTAL
Intervention: Sterile adherent film used during CVC insertion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Current hospital protocol for CVC insertion
Number of subjects: 100
Study: 16554448

Group type: EXPERIMENTAL
Intervention: Methylprednisolone 0.6 mg/kg ideal body weight
Number of subjects: 10
Study: 12929058

Group type: EXPERIMENTAL
Intervention: Ultrathin transnasal (UT) EGD
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ultrathin oral (UO) EGD
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard (SO) EGD
Number of subjects: 200
Study: 10908136

Group type: EXPERIMENTAL
Intervention: Vehicle data recorders
Number of subjects: 840

Group type: COMPARATOR
Intervention: Control group (non-equipped vehicles)
Number of subjects: 840
Study: 9379783

Group type: COMPARATOR
Intervention: Dotarizine 50 mg (single dose)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Dotarizine 100 mg (single dose)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Dotarizine 200 mg (single dose)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Dotarizine 50 mg (twice daily for 14 days)
Number of subjects: 16
Study: 1588379

Group type: EXPERIMENTAL
Intervention: AG plus HC (250 mg AG twice a day, 20 mg HC twice a day)
Number of subjects: 153

Group type: COMPARATOR
Intervention: AG (250 mg AG twice a day)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: AG plus HC
Number of subjects: 153

Group type: COMPARATOR
Intervention: AG
Number of subjects: 153
Study: 3838405

Group type: EXPERIMENTAL
Intervention: Molsidomine (4 mg, sublingually administered)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (sublingually administered)
Number of subjects: 7
Study: 30658621

Group type: EXPERIMENTAL
Intervention: Group Acceptance and Commitment Therapy (ACT) intervention delivered over 7 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care control condition
Number of subjects: 100
Study: 29072800

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo daily
Number of subjects: 32
Study: 26952225

Group type: EXPERIMENTAL
Intervention: Pregabalin 150mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 0
Study: 24666619

Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention (PCI)
Number of subjects: 1352

Group type: COMPARATOR
Intervention: Coronary Artery Bypass Grafting (CABG)
Number of subjects: 1352
Study: 22730105

Group type: EXPERIMENTAL
Intervention: Olanzapine monotherapy (flexible-dose for 8 weeks)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 20205704

Group type: EXPERIMENTAL
Intervention: One year low‐intensity computer‐tailored energy balance programme
Number of subjects: 413

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 413
Study: 18700217

Group type: EXPERIMENTAL
Intervention: Structured risk assessment following admission with mandatory evaluation of prevention in high-risk patients
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control wards (no structured risk assessment)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Structured risk assessment
Number of subjects: 14
Study: 15972022

Group type: EXPERIMENTAL
Intervention: Patients with CIHD
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study: 12788576

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus strain GG (ATCC 53103)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 10483607

Group type: EXPERIMENTAL
Intervention: 20 mg/m2 calcium folinate
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 100 mg/m2 calcium folinate
Number of subjects: 16

Group type: COMPARATOR
Intervention: 650 mg/m2/d fluorouracil
Number of subjects: 16
Study: 8724043

Group type: EXPERIMENTAL
Intervention: Liposomal daunorubicin 40 mg/m2 every 2 weeks for 12 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Observation for 12 weeks
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Liposomal daunorubicin
Number of subjects: 29
Study: 1929343

Group type: EXPERIMENTAL
Intervention: Single-dose amoxicillin-clavulanate combination
Number of subjects: 109

Group type: COMPARATOR
Intervention: 3-day regimen of amoxicillin-clavulanate
Number of subjects: 109
Study: 6749280

Group type: EXPERIMENTAL
Intervention: CCNU and hydroxyurea for one year
Number of subjects: 865

Group type: COMPARATOR
Intervention: No adjuvant therapy
Number of subjects: 865
Study: 30746581

Group type: EXPERIMENTAL
Intervention: Yisaipu® tapering (50 mg every other week from week 13 to week 24)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Full-dose therapy (50 mg/week for the entire study duration)
Number of subjects: 136
Study: 28371248

Group type: EXPERIMENTAL
Intervention: Targeted group administered antibiotics based on bile culture results
Number of subjects: 126

Group type: COMPARATOR
Intervention: Standard group administered cefmetazole
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Targeted group (specific procedures: pancreaticoduodenectomy)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Targeted group (specific procedures: hepatectomy)
Number of subjects: 126
Study: 26410119

Group type: EXPERIMENTAL
Intervention: Virtual reality exposure therapy (VRET) with social interactions; two exposure sessions
Number of subjects: 34
Study: 23568017

Group type: EXPERIMENTAL
Intervention: Pentax‐AWS Airway Scope (AWS‐I)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Airtraq laryngoscope (ATQ)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Miller laryngoscope
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Miller laryngoscope and Airtraq laryngoscope (ATQ)
Number of subjects: 23
Study: 21332852

Group type: EXPERIMENTAL
Intervention: Horizontal Scrub method
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Modified Bass method
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both methods
Number of subjects: 60
Study: 19515296

Group type: EXPERIMENTAL
Intervention: Combined intervention (parenting handbook + BASICS)
Number of subjects: 1275

Group type: COMPARATOR
Intervention: Parent intervention only
Number of subjects: 1275

Group type: COMPARATOR
Intervention: BASICS only
Number of subjects: 1275

Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 1275
Study: 16690793

Group type: EXPERIMENTAL
Intervention: Acute plasma volume expansion (APVE)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (Con)
Number of subjects: 8
Study: 15256675

Group type: EXPERIMENTAL
Intervention: ACE inhibitor therapy (perindopril, 4 mg daily)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 19
Study: 11778855

Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide whitening solution
Number of subjects: 0
Study: 9402352

Group type: EXPERIMENTAL
Intervention: Ranitidine (300 mg q.d. for 6 weeks)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Ranitidine (300 mg q.d. for 6 weeks) with amoxicillin (500 mg t.i.d.) and metronidazole (500 mg b.i.d.) for the first 12 days
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (120 mg q.i.d. for 6 weeks) with amoxicillin and metronidazole (at same dosages as in group B)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (non-eradicated H. pylori)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (eradicated H. pylori)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Ranitidine with amoxicillin and metronidazole (group B)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate with amoxicillin and metronidazole (group C)
Number of subjects: 122
Study: 7966736

Group type: EXPERIMENTAL
Intervention: 1-stage hypospadias repair using a preputial free graft for neourethral construction and a preputial pedicle flap for ventral skin coverage
Number of subjects: 77
Study: 3036903

Group type: COMPARATOR
Intervention: no dexamethasone (DEX), enflurane anesthesia
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 40 mg DEX, iv, 45-60 min before sternotomy, enflurane anesthesia
Number of subjects: 25

Group type: COMPARATOR
Intervention: no DEX, fentanyl anesthesia (50-100 micrograms/kg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: DEX, fentanyl anesthesia
Number of subjects: 25
Study: 31728664

Group type: EXPERIMENTAL
Intervention: Drospirenone 4 mg (DRSP)
Number of subjects: 858

Group type: COMPARATOR
Intervention: Desogestrel 0.075 mg (DSG)
Number of subjects: 858
Study: 28699562

Group type: EXPERIMENTAL
Intervention: Camino Verde intervention
Number of subjects: 90
Study: 26325644

Group type: EXPERIMENTAL
Intervention: Surgical debridement (SD)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nonsurgical debridement (NSD)
Number of subjects: 21
Study: 23247002

Group type: EXPERIMENTAL
Intervention: Etoricoxib 120 mg
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Etoricoxib 90 mg
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Ibuprofen 600 mg
Number of subjects: 588

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: A/C
Number of subjects: 588
Study: 21540755

Group type: EXPERIMENTAL
Intervention: Escitalopram 10 mg/day
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Escitalopram 20 mg/day
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 18500152

Group type: EXPERIMENTAL
Intervention: CaviStat mint confection (BasicMints)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sugarless mint control (without CaviStat)
Number of subjects: 200
Study: 16504528

Group type: EXPERIMENTAL
Intervention: Video-thoracoscopy (VT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Transaxillary thoracotomy (TT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Posterolateral thoracotomy (PLT)
Number of subjects: 24
Study: 15504627

Group type: EXPERIMENTAL
Intervention: Active TSE machine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Inactive TSE machine
Number of subjects: 8
Study: 11269770

Group type: EXPERIMENTAL
Intervention: Pressure bandage
Number of subjects: 420

Group type: COMPARATOR
Intervention: No pressure bandage
Number of subjects: 420
Study: 9715220

Group type: EXPERIMENTAL
Intervention: Pediatric advanced life support (PALS) training
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Basic life support training
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Pediatric advanced life support (PALS) training for support staff
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Availability of intraosseous needles
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Availability of endotracheal tubes
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Availability of oxygen tanks
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Availability of intravenous catheters
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Availability of nebulizers
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Availability of epinephrine 1:1,000
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Availability of calcium chloride
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Emergency plans designed by pediatricians
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Conducting mock drills
Number of subjects: 240
Study: 7912442

Group type: EXPERIMENTAL
Intervention: Visible white light (10,000 lux)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Visible red light (175 lux)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both light treatment conditions
Number of subjects: 35
Study: 2660552

Group type: COMPARATOR
Intervention: Cimetidine 400 mg twice daily
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Sucralfate 2 g twice daily
Number of subjects: 76
Study: 31719527

Group type: EXPERIMENTAL
Intervention: 7.5% CO2 inhalation
Number of subjects: 72
Study: 28392369

Group type: EXPERIMENTAL
Intervention: Continuous Chest Compression (CCC) CPR
Number of subjects: 14109

Group type: COMPARATOR
Intervention: 30:2 CPR
Number of subjects: 14109
Study: 26226173

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser at 3 W, 30 mJ per pulse, contact mode, 300 μm diameter optic fiber
Number of subjects: 20

Group type: COMPARATOR
Intervention: Surgical stripping
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser
Number of subjects: 20
Study: 22733833

Group type: EXPERIMENTAL
Intervention: Dabigatran (150 mg twice a day, switching to 110 mg twice a day at age 80)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 65

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 65
Study: 21054671

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Eformoterol
Number of subjects: 9
Study: 19934816

Group type: EXPERIMENTAL
Intervention: 1.25 mg bevacizumab
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 2.5 mg bevacizumab
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 50
Study: 16467663

Group type: EXPERIMENTAL
Intervention: Nebivolol (5 mg daily for 6 months)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Metoprolol (100 mg daily for 6 months)
Number of subjects: 80
Study: 15164111

Group type: EXPERIMENTAL
Intervention: Cow's milk consumption >500 g/day
Number of subjects: 94

Group type: COMPARATOR
Intervention: Cow's milk consumption <500 g/day
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Weight gain from birth to 2 years
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Iron-depleted children
Number of subjects: 94